{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:44:13Z","timestamp":1793835853584,"version":"4.6.1"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.1001\/jamaoto.2022.1190","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T15:33:10Z","timestamp":1654183990000},"page":"654","source":"Crossref","is-referenced-by-count":26,"title":["Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis"],"prefix":"10.1001","volume":"148","author":[{"given":"Jana","family":"Smahelova","sequence":"first","affiliation":[{"name":"Department of Genetics and Microbiology, Faculty of Science, BIOCEV, Charles University, Prague, Czech Republic"},{"name":"Institute of Hematology and Blood Transfusion, National Reference Laboratory for Papillomaviruses and Polyomaviruses, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hamsikova","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Blood Transfusion, National Reference Laboratory for Papillomaviruses and Polyomaviruses, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viera","family":"Ludvikova","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Blood Transfusion, National Reference Laboratory for Papillomaviruses and Polyomaviruses, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Vydrova","sequence":"additional","affiliation":[{"name":"Prague Voice Centre\/Medical Healthcom, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Traboulsi","sequence":"additional","affiliation":[{"name":"Department of ENT\/Head and Neck Surgery, Na Homolce Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Vencalek","sequence":"additional","affiliation":[{"name":"Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacky University, Olomouc, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Luke\u0161","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology and Head and Neck Surgery, First Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Tachezy","sequence":"additional","affiliation":[{"name":"Department of Genetics and Microbiology, Faculty of Science, BIOCEV, Charles University, Prague, Czech Republic"},{"name":"Institute of Hematology and Blood Transfusion, National Reference Laboratory for Papillomaviruses and Polyomaviruses, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"ooi220027r1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/MOO.0000000000000490","article-title":"Recurrent respiratory papillomatosis: update 2018.","volume":"26","author":"Derkay","year":"2018","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"6","key":"ooi220027r2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/MOO.0b013e328316930e","article-title":"Recurrent respiratory papillomatosis: update 2008.","volume":"16","author":"Gallagher","year":"2008","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"6","key":"ooi220027r3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216697","article-title":"Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis.","volume":"14","author":"Buchinsky","year":"2019","journal-title":"PLoS One"},{"key":"ooi220027r4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/285486","article-title":"The role of NBI HDTV magnifying endoscopy in the prehistologic diagnosis of laryngeal papillomatosis and spinocellular cancer.","volume":"2014","author":"Lukes","year":"2014","journal-title":"Biomed Res Int"},{"issue":"8","key":"ooi220027r5","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/lary.v122.8","article-title":"Narrow band imaging is a new technique in visualization of recurrent respiratory papillomatosis.","volume":"122","author":"Tjon Pian Gi","year":"2012","journal-title":"Laryngoscope"},{"issue":"1","key":"ooi220027r6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/lio2.v3.1","article-title":"Current and future management of recurrent respiratory papillomatosis.","volume":"3","author":"Ivancic","year":"2018","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"2","key":"ooi220027r7","first-page":"956","article-title":"Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.","volume":"24","author":"Gazia","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"ooi220027r8","doi-asserted-by":"publisher","first-page":"E1941","DOI":"10.1002\/lary.v131.6","article-title":"Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement.","volume":"131","author":"Sidell","year":"2021","journal-title":"Laryngoscope"},{"issue":"3","key":"ooi220027r9","doi-asserted-by":"publisher","first-page":"E921","DOI":"10.1002\/lary.v131.3","article-title":"Parenteral bevacizumab for the treatment of severe respiratory papillomatosis in an adult population.","volume":"131","author":"Tkaczuk","year":"2021","journal-title":"Laryngoscope"},{"issue":"1","key":"ooi220027r10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40425-019-0603-3","article-title":"Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.","volume":"7","author":"Allen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"ooi220027r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2019.100185","article-title":"Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions: a review of the literature.","volume":"8","author":"Pattyn","year":"2019","journal-title":"Papillomavirus Res"},{"issue":"4","key":"ooi220027r12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/bjc.2015.462","article-title":"Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids.","volume":"114","author":"Handisurya","year":"2016","journal-title":"Br J Cancer"},{"issue":"3","key":"ooi220027r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230106","article-title":"In RRP, serologic response to HPV is frequently absent and slow to develop.","volume":"15","author":"Buchinsky","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"ooi220027r14","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s00405-016-4085-3","article-title":"Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis.","volume":"273","author":"Tjon Pian Gi","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"10197","key":"ooi220027r15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"issue":"10316","key":"ooi220027r16","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"ooi220027r17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/21645515.2020.1839292","article-title":"Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up.","volume":"17","author":"Kjaer","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"14","key":"ooi220027r18","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer.","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"ooi220027r19","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/ijc.v142.10","article-title":"Vaccination protects against invasive HPV-associated cancers.","volume":"142","author":"Luostarinen","year":"2018","journal-title":"Int J Cancer"},{"issue":"3","key":"ooi220027r20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1200\/JCO.2017.75.0141","article-title":"Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States.","volume":"36","author":"Chaturvedi","year":"2018","journal-title":"J Clin Oncol"},{"issue":"5","key":"ooi220027r21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/cid\/ciab171","article-title":"Significant declines in juvenile-onset recurrent respiratory papillomatosis following human papillomavirus (HPV) vaccine introduction in the United States.","volume":"73","author":"Meites","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ooi220027r22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/infdis\/jix498","article-title":"A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program.","volume":"217","author":"Novakovic","year":"2018","journal-title":"J Infect Dis"},{"key":"ooi220027r23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.33321\/cdi","article-title":"Australian Paediatric Surveillance Unit (APSU) annual surveillance report 2019.","volume":"44","author":"Teutsch","year":"2020","journal-title":"Commun Dis Intell (2018)"},{"issue":"6","key":"ooi220027r24","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3437","article-title":"Nonavalent human papillomavirus vaccination as a treatment for skin warts in immunosuppressed adults: a case series.","volume":"100","author":"Bossart","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"ooi220027r25","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamaoto.2016.4736","article-title":"Adjuvant human papillomavirus vaccination for secondary prevention: a systematic review.","volume":"143","author":"Dion","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"41","key":"ooi220027r26","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1016\/j.vaccine.2020.07.055","article-title":"Prophylactic HPV vaccination after conization: a systematic review and meta-analysis.","volume":"38","author":"Jentschke","year":"2020","journal-title":"Vaccine"},{"issue":"7","key":"ooi220027r27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/cid\/cir1036","article-title":"Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study.","volume":"54","author":"Swedish","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ooi220027r28","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/infdis\/jiy616","article-title":"Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis.","volume":"219","author":"Rosenberg","year":"2019","journal-title":"J Infect Dis"},{"issue":"11","key":"ooi220027r29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079156","article-title":"Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women.","volume":"8","author":"Tachezy","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"ooi220027r30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/apm.2017.125.issue-6","article-title":"The prevalence of HPV infections in HPV-vaccinated women from the general population.","volume":"125","author":"Hamsikova","year":"2017","journal-title":"APMIS"},{"issue":"1","key":"ooi220027r31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/(ISSN)1096-9071","article-title":"Antibody response to a synthetic peptide derived from the human papillomavirus type 6\/11 L2 protein in recurrent respiratory papillomatosis: correlation between Southern blot hybridization, polymerase chain reaction, and serology.","volume":"42","author":"Tachezy","year":"1994","journal-title":"J Med Virol"},{"issue":"4","key":"ooi220027r32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/vim.2010.0014","article-title":"Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA.","volume":"23","author":"Durzynska","year":"2010","journal-title":"Viral Immunol"},{"key":"ooi220027r33","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1016\/j.vaccine.2017.11.089","article-title":"Immunogenicity of HPV prophylactic vaccines: serology assays and their use in HPV vaccine evaluation and development.","volume":"36","author":"Pinto","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"ooi220027r34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/sextrans-2012-050486","article-title":"Cross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic.","volume":"89","author":"Hamsikova","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"7","key":"ooi220027r35","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1086\/599179","article-title":"Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.","volume":"200","author":"Markowitz","year":"2009","journal-title":"J Infect Dis"},{"issue":"11","key":"ooi220027r36","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1086\/589700","article-title":"Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.","volume":"46","author":"Newall","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ooi220027r37","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1288\/00005537-198706000-00005","article-title":"Laryngeal papillomatosis: clinical, histopathologic and molecular studies.","volume":"97","author":"Abramson","year":"1987","journal-title":"Laryngoscope"},{"issue":"8","key":"ooi220027r38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042171","article-title":"Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study.","volume":"7","author":"Rautava","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"ooi220027r39","doi-asserted-by":"publisher","first-page":"822","DOI":"10.5604\/12321966.1129940","article-title":"Prevalence of human papillomavirus (HPV) in upper respiratory tract mucosa in a group of pre-school children.","volume":"21","author":"Szydlowski","year":"2014","journal-title":"Ann Agric Environ Med"},{"issue":"6-7","key":"ooi220027r40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/apm.2010.118.issue-6-7","article-title":"Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.","volume":"118","author":"Bonagura","year":"2010","journal-title":"APMIS"},{"issue":"2","key":"ooi220027r41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/cei.13387","article-title":"Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.","volume":"199","author":"Ivancic","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"ooi220027r42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/0003489418821695","article-title":"Implementation of routine HPV vaccination in the management of recurrent respiratory papillomatosis.","volume":"128","author":"Yiu","year":"2019","journal-title":"Ann Otol Rhinol Laryngol"}],"container-title":["JAMA Otolaryngology\u2013Head & Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2792657\/jamaotolaryngology_smahelova_2022_oi_220027_1657291150.4426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T15:01:58Z","timestamp":1657810918000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2792657"}},"subtitle":["A Nonrandomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2022.1190","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}